Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Poxvirus-based vectors as vaccine candidates

S Pincus1, J Tartaglia, E Paoletti

  • 1Virogenetics Corporation, Troy, New York 12180, USA.

Biologicals : Journal of the International Association of Biological Standardization
|June 1, 1995
PubMed
Summary

New vaccinia vaccine vectors, NYVAC and ALVAC, improve safety. These engineered vectors can express multiple genes, advancing vaccine development for human and veterinary use.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gliptin- and immune checkpoint inhibitor-induced bullous pemphigoid: a real-life comparative study with idiopathic bullous pemphigoid.

Annales de dermatologie et de venereologie·2026
Same author

Economic Evaluation of Patiromer in Patients with Concomitant Heart Failure and Chronic Kidney Disease in Italy.

PharmacoEconomics - open·2025
Same author

Pragmatic diagnostic and therapeutic algorithms to optimize new potassium binder use in cardiorenal disease.

Pharmacological research·2022
Same author

Chronic ozone exposure preferentially modifies root rather than foliar metabolism of date palm (Phoenix dactylifera) saplings.

The Science of the total environment·2021
Same author

Exploring new strategies for ozone-risk assessment: A dynamic-threshold case study.

Environmental pollution (Barking, Essex : 1987)·2021
Same author

Ten-Year Efficacy and Safety of Once-Daily Tacrolimus in Kidney Transplant: A Prospective Cohort Study.

Transplantation proceedings·2020

Area of Science:

  • Vaccinology
  • Molecular Biology
  • Virology

Background:

  • Safety concerns historically limited vaccinia-based vaccine candidates.
  • NYVAC and ALVAC represent advancements in vaccinia vector technology.

Purpose of the Study:

  • To highlight the development and potential of NYVAC and ALVAC vectors.
  • To underscore their utility in creating novel vaccines.

Main Methods:

  • Engineering of vaccinia vectors (NYVAC, ALVAC) for gene expression.
  • Assessment of vector safety and expression capabilities.

Main Results:

  • NYVAC and ALVAC vectors have addressed prior safety issues.
  • These vectors demonstrate capacity for expressing multiple heterologous genes.

Conclusions:

  • NYVAC and ALVAC are promising platforms for vaccine development.
  • Ongoing research focuses on their application in human and veterinary medicine.

Related Experiment Videos